Movement Alert｜Illumina Intraday Rise 5.09% in Regular Trading, Rebound Followed Earlier Post-Earnings Selloff and Broader Sector Strength

Market Focus11-03 22:52

On November 3, Illumina rose 5.09% in Regular Trading, trading at $236.79, with turnover of $46.0823 million.

The most recent market update indicates the move came as selling pressure after the latest quarterly report eased, while Life Sciences Tools & Services names also moved higher, including Waters up 5.01%, REVVITY INC up 11.41%, Thermo Fisher Scientific up 1.6%, Tempus AI up 3.75%, and Danaher up 1.49%.

Background remains tied to Illumina's latest quarterly results released on October 29: adjusted EPS excluding tariff refunds was $1.44 versus a $1.36 consensus estimate, but revenue was $1.129 billion, below the $1.154 billion expectation. The company also lifted full-year adjusted EPS guidance to $5.40-$5.45, yet investors remained focused on softer revenue and pressure in China, where revenue declined 0.1% year over year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment